CLOMIPHENE CITRATE
Details
- Status
- Prescription
- First Approved
- 1999-08-30
- Routes
- ORAL
- Dosage Forms
- TABLET
CLOMIPHENE CITRATE Approval History
What CLOMIPHENE CITRATE Treats
5 indicationsCLOMIPHENE CITRATE is approved for 5 conditions since its original approval in 1999. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Ovulatory Dysfunction
- Polycystic Ovary Syndrome
- Amenorrhea-Galactorrhea Syndrome
- Psychogenic Amenorrhea
- Secondary Amenorrhea
Drugs Similar to CLOMIPHENE CITRATE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CLOMIPHENE CITRATE FDA Label Details
ProIndications & Usage
INDICATIONS & USAGE Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome (see WARNINGS: Ovarian Hyperstimulation Syndrome ), amenorrhea-galactorrhea syndrome, psychogenic amenorrhea, post-oral-contraceptive amenorrhea, and certain cases of secondary amenorrhea of undetermined etiology. Properly timed coitus in ...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.